There appear to be a number of changes to sphingolipid metabolism that are common to multiple cancers, including the well-studied up-regulation of SPHK1, loss of ASM activity and altered lysosomal sphingolipid flux, and potentially an overall increase in sphingolipid biosynthesis, although the latter certainly requires further investigation. Here, SPHK1 is linked to cancer.